Biofrontera Inc.
BFRI
$0.801
$0.0020.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.56M | 9.01M | 7.84M | 7.91M | 10.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.56M | 9.01M | 7.84M | 7.91M | 10.60M |
| Cost of Revenue | 5.27M | 4.88M | 4.34M | 4.12M | 5.37M |
| Gross Profit | 7.29M | 4.14M | 3.50M | 3.80M | 5.23M |
| SG&A Expenses | 8.22M | 8.43M | 7.95M | 9.25M | 9.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.27M | 13.97M | 12.91M | 13.38M | 14.46M |
| Operating Income | -1.71M | -4.96M | -5.07M | -5.47M | -3.87M |
| Income Before Tax | -1.40M | -5.67M | -237.00K | -10.44M | 3.52M |
| Income Tax Expenses | -3.00K | 3.00K | 20.00K | 1.00K | -6.00K |
| Earnings from Continuing Operations | -1.40M | -5.67M | -257.00K | -10.44M | 3.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.40M | -5.67M | -257.00K | -10.44M | 3.53M |
| EBIT | -1.71M | -4.96M | -5.07M | -5.47M | -3.87M |
| EBITDA | -1.68M | -4.83M | -4.94M | -5.34M | -3.74M |
| EPS Basic | -0.18 | -0.98 | -0.05 | -2.88 | 1.65 |
| Normalized Basic EPS | -0.24 | -0.61 | -0.03 | -1.75 | -0.94 |
| EPS Diluted | -0.37 | -0.98 | -0.05 | -2.88 | 1.65 |
| Normalized Diluted EPS | -0.24 | -0.61 | -0.03 | -1.75 | -0.94 |
| Average Basic Shares Outstanding | 7.57M | 5.77M | 5.09M | 3.62M | 2.14M |
| Average Diluted Shares Outstanding | 7.57M | 5.77M | 5.09M | 3.62M | 2.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
